Agronomics (LSE:ANIC), the Investment company focused on cellular agriculture and precision fermentation, told the market on 29 September 2026 that its largest holding, Liberation Bioindustries, needs about 25 million dollars of further funding to finish its plant. The update, followed by a net asset value statement on 20 October, put the portfolio in sharper focus for anyone tracking the FTSE AIM All Share Index.

What the company does

Agronomics is an investment company that invests in companies developing food and materials through cellular agriculture, biotechnology and fermentation, aiming to replace conventional animal-based production. Jim Mellon is its executive chair. Its holdings include Liberation Bioindustries, Meatly, Bond Pet Foods, HydGene, SuperMeat and Tropic, among others, and it reports a net asset value regularly rather than Earnings in the usual sense.

The Liberation update

According to the 29 September update, a strategic review looked at selling the Richmond Facility or forming a joint venture, but no acceptable offers emerged, so Liberation will proceed alone. Delays and higher costs have pushed the completion target beyond the fourth quarter of 2026, and first production is expected about six months after the new funding is secured, pointing to the first half of 2027. Liberation has so far deployed 125 million dollars of Capital and Debt on construction.

Agronomics valued its investment in Liberation at 35.28 million pounds at 30 June 2026, around a quarter of its net asset value of roughly 140 million pounds. LSE:ANIC said it did not currently expect the delays to have a material effect on that valuation.

Other portfolio news

On 7 May 2026, Meatly completed a 10.4 million pound Series A round with new investors including Clean Growth Fund, Oyster Bay and JamJar Ventures. Agronomics has invested 1.1 million pounds in Meatly since inception, holds a stake of 11.57% on a fully diluted basis, and carried the position at 3.2 million pounds, down from 4.5 million pounds at 31 December 2025. Meatly plans a 20,000-litre bioreactor facility in London and expects product launches in 2027, focused on pet food.

On 12 May, Agronomics led a 5 million dollar investment in SuperMeat, and on 25 June it announced that portfolio company Tropic had acquired Rahan Meristem. Updates on HydGene and Bond Pet Foods followed on 4 June. LSE:ANIC published net asset value statements for 31 March, 30 June and 30 September 2026.

Financial picture

As an investment company, Agronomics reports net asset value rather than earnings in the usual sense, and its financial health rests on portfolio valuations and the cash available to support follow-on funding rounds. The share price relative to net asset value is a recurring theme for investment companies of this kind, and the valuation of unquoted holdings depends on funding rounds and management estimates.

Sector and index context

Alternative protein and fermentation businesses have faced a tougher funding climate, with investors demanding clearer routes to production and revenue. Agronomics (LSE:ANIC) sits on AIM as one of the few listed vehicles offering exposure to the theme, which means sentiment towards the sector often shows up directly in its shares.

Key risks

Concentration is the main risk, as Liberation alone represents about a quarter of net asset value and still needs substantial funding. Construction delays, cost inflation, difficulty raising capital and regulatory approvals for novel foods could all affect valuations. Unquoted holdings can be revalued after a funding round.

What to watch next

Investors will look for news on how Liberation secures its 25 million dollar funding gap and whether the first-production timeline of the first half of 2027 holds. The next net asset value update, further follow-on investments and the timing of Meatly's London facility will also give a read on portfolio progress.